XML 133 R34.htm IDEA: XBRL DOCUMENT v3.22.4
LOANS RECEIVABLE AND INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Loans Receivable And Investments [Abstract]  
Loans Receivable And Investments The following is a summary of our loans receivable and investments, net, including amortized cost, fair value and unrealized gains or losses on available for sale investments (dollars in thousands):
Amortized CostAllowanceUnrealized GainCarrying AmountFair Value
As of December 31, 2022:
Secured/mortgage loans and other, net (1)
$513,669 $(20,000)$— $493,669 $493,627 
Government-sponsored pooled loan investments, net (2)
43,406 — — 43,406 43,406 
Total investments reported as secured loans receivable and investments, net
557,075 (20,000)— 537,075 537,033 
Non-mortgage loans receivable, net (3)
28,959 (4,621)— 24,338 23,416 
Total loans receivable and investments, net$586,034 $(24,621)$— $561,413 $560,449 
As of December 31, 2021:
Secured/mortgage loans and other, net (1)
$488,913 $— $— $488,913 $478,931 
Government-sponsored pooled loan investments, net (2)
39,376 — 1,836 41,213 41,213 
Total investments reported as secured loans receivable and investments, net
528,289 — 1,836 530,126 520,144 
Non-mortgage loans receivable, net (3)
24,418 (5,394)— 19,024 19,039 
Total loans receivable and investments, net$552,707 $(5,394)$1,836 $549,150 $539,183 
______________________________
(1)Includes the $486.1 million principal amount, cash-pay Santerre Mezzanine Loan, which is priced at LIBOR + 6.42% and secured by a pledge of equity interests in entities that hold a diverse pool of medical office, senior housing, skilled nursing and other healthcare assets. The Santerre Mezzanine loan has a current maturity date of June 9, 2023, subject to the borrower’s right to extend for one year,subject to satisfaction of certain conditions. The Santerre Mezzanine Loan is currently prepayable in whole or in part subject to satisfaction of certain financial and non-financial terms and conditions. Other included investments have contractual maturities in 2024 and 2027.
(2)Repaid at par in February 2023.
(3)Included in other assets on our Consolidated Balance Sheets.